Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

5 months after launch, Allogene guns for $100M IPO

fiercebiotechSeptember 18, 2018

Tag: CAR-T , acute lymphoblastic leukemia , IPO

PharmaSources Customer Service